Fulgent Genetics, Inc. FLGT Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $50.19M-9.0% | $55.14M-43.4% | $97.47M+22.6% | $79.51M-51.8% | ||
| $285.88M+40.9% | $202.96M— | —— | —— | ||
| $84.76M+22.8% | $69.02M+35.0% | $51.13M-3.1% | $52.75M-62.0% | ||
| $550.49M+55.7% | $353.57M-30.4% | $507.85M-19.1% | $627.87M+2.6% | ||
| $112.55M+6.6% | $105.55M+26.5% | $83.46M+2.6% | $81.35M+30.6% | ||
| $25.08M+13.7% | $22.06M0.0% | $22.06M-84.6% | $143.03M+181% | ||
| $64.79M-8.0% | $70.39M-50.8% | $143.05M-5.0% | $150.64M+319% | ||
| $1.21B-0.5% | $1.22B-1.2% | $1.24B-10.9% | $1.39B+8.4% | ||
| $18.65M+1.6% | $18.36M+19.6% | $15.36M-33.5% | $23.09M+12.7% | ||
| $3.64M+62.7% | $2.23M-22.3% | $2.87M-10.2% | $3.2M-78.0% | ||
| $84.97M+16.6% | $72.9M-0.2% | $73.02M-17.1% | $88.11M-16.3% | ||
| $106.81M+17.6% | $90.81M-11.0% | $102.04M-12.2% | $116.18M+3.0% | ||
| $3K0.0% | $3K0.0% | $3K0.0% | $3K0.0% | ||
| $529.95M-10.2% | $590.47M-6.7% | $633.18M-21.0% | $801M+21.8% | ||
| $1.11B-1.9% | $1.13B-0.3% | $1.14B-10.3% | $1.27B+9.3% | ||
| $1.21B-0.5% | $1.22B-1.2% | $1.24B-10.9% | $1.39B+8.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Fulgent Genetics, Inc.'s total assets?
- Fulgent Genetics, Inc. (FLGT) holds $1.2B in total assets, down 4.1% year over year.
- How much debt does Fulgent Genetics, Inc. have?
- Fulgent Genetics, Inc. carries $8.2M in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Fulgent Genetics, Inc. have?
- Fulgent Genetics, Inc. holds $23.4M in cash and equivalents.
- Can Fulgent Genetics, Inc. cover its short-term obligations?
- Its current ratio is 5.31 — current assets exceed current liabilities.
- Where does Fulgent Genetics, Inc.'s balance sheet data come from?
- Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
